Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Non-inferiority designs comparing placebo to a proven therapy for childhood pneumonia in low-resource settings.

May S, Brown SP, Schmicker RH, Emerson SS, Nkwopara E, Ginsburg AS.

Clin Trials. 2019 Dec 8:1740774519888460. doi: 10.1177/1740774519888460. [Epub ahead of print]

PMID:
31814441
2.

Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi.

Nkwopara E, Schmicker R, Mvalo T, Phiri M, Phiri A, Couasnon M, McCollum ED, Ginsburg AS.

BMJ Open Respir Res. 2019 Sep 3;6(1):e000415. doi: 10.1136/bmjresp-2019-000415. eCollection 2019.

3.
4.
5.

Boosting quality diagnostics could give Africa better health.

Greenslade L, Ginsburg AS.

Lancet. 2019 Jun 22;393(10190):2492. doi: 10.1016/S0140-6736(19)30718-4. No abstract available.

PMID:
31232372
6.
7.

Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis.

Nkwopara E, Schmicker R, Mvalo T, May S, Ginsburg AS.

BMJ Open Respir Res. 2019 May 22;6(1):e000414. doi: 10.1136/bmjresp-2019-000414. eCollection 2019.

8.

World Health Organization Treatment Recommendations for Nonsevere Fast-Breathing Pneumonia Need to Be Updated-Reply.

Ginsburg AS, McCollum ED, May SJ.

JAMA Pediatr. 2019 Jun 1;173(6):608-609. doi: 10.1001/jamapediatrics.2019.0641. No abstract available.

PMID:
30985898
9.

How Uncertain Is Our Reference Standard for Respiratory Rate Measurement?

Ansermino JM, Dumont G, Ginsburg AS.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):1036-1037. doi: 10.1164/rccm.201812-2266LE. No abstract available.

PMID:
30673505
10.

Multicentre pilot study evaluation of lung ultrasound for the management of paediatric pneumonia in low-resource settings: a study protocol.

Lenahan JL, Volpicelli G, Lamorte A, Jehan F, Bassat Q, Ginsburg AS.

BMJ Open Respir Res. 2018 Dec 19;5(1):e000340. doi: 10.1136/bmjresp-2018-000340. eCollection 2018.

11.

The role of bacterial vaccines in the prevention of influenza mortality.

Klugman KP, Madhi SA, Ginsburg AS, Rodgers GL.

Lancet Glob Health. 2018 Dec;6(12):e1268-e1269. doi: 10.1016/S2214-109X(18)30445-5. No abstract available.

12.

Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.

Ginsburg AS, Mvalo T, Nkwopara E, McCollum ED, Ndamala CB, Schmicker R, Phiri A, Lufesi N, Izadnegahdar R, May S.

JAMA Pediatr. 2019 Jan 1;173(1):21-28. doi: 10.1001/jamapediatrics.2018.3407.

13.
14.

A Systematic Review of Tools to Measure Respiratory Rate in Order to Identify Childhood Pneumonia.

Ginsburg AS, Lenahan JL, Izadnegahdar R, Ansermino JM.

Am J Respir Crit Care Med. 2018 May 1;197(9):1116-1127. doi: 10.1164/rccm.201711-2233CI.

PMID:
29474107
15.

Pneumonia Risk Stratification Scores for Children in Low-Resource Settings: A Systematic Literature Review.

Deardorff KV, McCollum ED, Ginsburg AS.

Pediatr Infect Dis J. 2018 Aug;37(8):743-748. doi: 10.1097/INF.0000000000001883.

16.

Vaccination to reduce antimicrobial resistance.

Ginsburg AS, Klugman KP.

Lancet Glob Health. 2017 Dec;5(12):e1176-e1177. doi: 10.1016/S2214-109X(17)30364-9. Epub 2017 Nov 8. No abstract available.

17.

Outpatient Management of Children With World Health Organization Chest Indrawing Pneumonia: Implementation Risks and Proposed Solutions.

McCollum ED, Ginsburg AS.

Clin Infect Dis. 2017 Oct 16;65(9):1560-1564. doi: 10.1093/cid/cix543. Review.

18.

Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.

Ginsburg AS, Meghani A, Halstead SB, Yaich M.

Hum Vaccin Immunother. 2017 Oct 3;13(10):2222-2231. doi: 10.1080/21645515.2017.1356496. Epub 2017 Aug 25. Review.

19.

A model for oxygen conservation associated with titration during pediatric oxygen therapy.

Wu G, Wollen A, Himley S, Austin G, Delarosa J, Izadnegahdar R, Ginsburg AS, Zehrung D.

PLoS One. 2017 Feb 24;12(2):e0171530. doi: 10.1371/journal.pone.0171530. eCollection 2017.

20.

Reservoir Cannulas for Pediatric Oxygen Therapy: A Proof-of-Concept Study.

Wu G, Wollen A, DiBlasi RM, Himley S, Saxon E, Austin G, Delarosa J, Izadnegahdar R, Ginsburg AS, Zehrung D.

Int J Pediatr. 2016;2016:9214389. doi: 10.1155/2016/9214389. Epub 2016 Nov 23.

21.

Reduction of childhood pneumonia mortality in the Sustainable Development era.

McCollum ED, King C, Hammitt LL, Ginsburg AS, Colbourn T, Baqui AH, O'Brien KL.

Lancet Respir Med. 2016 Dec;4(12):932-933. doi: 10.1016/S2213-2600(16)30371-X. Epub 2016 Nov 12. No abstract available.

22.

World Pneumonia Day 2016: pulse oximetry and oxygen.

Ginsburg AS, Izadnegahdar R, Klugman KP.

Lancet Glob Health. 2016 Dec;4(12):e893-e894. doi: 10.1016/S2214-109X(16)30296-0. Epub 2016 Nov 10. No abstract available.

23.

mPneumonia, an Innovation for Diagnosing and Treating Childhood Pneumonia in Low-Resource Settings: A Feasibility, Usability and Acceptability Study in Ghana.

Ginsburg AS, Tawiah Agyemang C, Ambler G, Delarosa J, Brunette W, Levari S, Larson C, Sundt M, Newton S, Borriello G, Anderson R.

PLoS One. 2016 Oct 27;11(10):e0165201. doi: 10.1371/journal.pone.0165201. eCollection 2016.

24.

A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).

Jehan F, Nisar MI, Kerai S, Brown N, Balouch B, Hyder Z, Ambler G, Ginsburg AS, Zaidi AK.

BMC Infect Dis. 2016 Jan 13;16:13. doi: 10.1186/s12879-015-1334-9.

25.

Undernutrition and pneumonia mortality.

Ginsburg AS, Izadnegahdar R, Berkley JA, Walson JL, Rollins N, Klugman KP.

Lancet Glob Health. 2015 Dec;3(12):e735-6. doi: 10.1016/S2214-109X(15)00222-3. No abstract available.

26.

Optimising adherence to childhood pneumonia treatment: the design and development of patient instructions and a job aid for amoxicillin dispersible tablets.

Ebels K, Faulx D, Gerth-Guyette E, Murunga P, Mahapatro S, Das MK, Ginsburg AS.

Arch Dis Child. 2016 Jan;101(1):57-62. doi: 10.1136/archdischild-2015-308543. Epub 2015 Oct 21.

PMID:
26489802
27.

mPneumonia: Development of an Innovative mHealth Application for Diagnosing and Treating Childhood Pneumonia and Other Childhood Illnesses in Low-Resource Settings.

Ginsburg AS, Delarosa J, Brunette W, Levari S, Sundt M, Larson C, Tawiah Agyemang C, Newton S, Borriello G, Anderson R.

PLoS One. 2015 Oct 16;10(10):e0139625. doi: 10.1371/journal.pone.0139625. eCollection 2015.

28.

Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review.

Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS.

J Med Internet Res. 2015 Feb 24;17(2):e52. doi: 10.2196/jmir.3951. Review.

29.

Prevention of neonatal pneumonia and sepsis via maternal immunisation.

Ginsburg AS, Meulen AS, Klugman KP.

Lancet Glob Health. 2014 Dec;2(12):e679-80. doi: 10.1016/S2214-109X(14)70317-1. Epub 2014 Nov 12. No abstract available.

30.

Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product.

Zaman K, Naser AM, Power M, Yaich M, Zhang L, Ginsburg AS, Luby SP, Rahman M, Hills S, Bhardwaj M, Flores J.

Vaccine. 2014 Oct 21;32(46):6061-6. doi: 10.1016/j.vaccine.2014.09.012. Epub 2014 Sep 18.

PMID:
25239483
31.

Innovations in pneumonia diagnosis and treatment: a call to action on World Pneumonia Day, 2013.

Ginsburg AS, Sadruddin S, Klugman KP.

Lancet Glob Health. 2013 Dec;1(6):e326-7. doi: 10.1016/S2214-109X(13)70117-7. Epub 2013 Nov 12. No abstract available.

32.

Oxygen and pulse oximetry in childhood pneumonia: surveys of clinicians and student clinicians in Cambodia.

Ginsburg AS, Gerth-Guyette E, Mollis B, Gardner M, Chham S.

Trop Med Int Health. 2014 May;19(5):537-44. doi: 10.1111/tmi.12291. Epub 2014 Mar 17.

33.

Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis of three decades of published studies.

Ginsburg AS, Tinkham L, Riley K, Kay NA, Klugman KP, Gill CJ.

Int J Antimicrob Agents. 2013 Dec;42(6):482-91. doi: 10.1016/j.ijantimicag.2013.08.012. Epub 2013 Sep 23. Review.

PMID:
24139883
34.

Issues and challenges in the development of pneumococcal protein vaccines.

Ginsburg AS, Nahm MH, Khambaty FM, Alderson MR.

Expert Rev Vaccines. 2012 Mar;11(3):279-85. doi: 10.1586/erv.12.5. Review.

35.

Oxygen and pulse oximetry in childhood pneumonia: a survey of healthcare providers in resource-limited settings.

Ginsburg AS, Van Cleve WC, Thompson MI, English M.

J Trop Pediatr. 2012 Oct;58(5):389-93. doi: 10.1093/tropej/fmr103. Epub 2011 Dec 14.

PMID:
22170511
36.

Estimated global incidence of Japanese encephalitis: a systematic review.

Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS.

Bull World Health Organ. 2011 Oct 1;89(10):766-74, 774A-774E. doi: 10.2471/BLT.10.085233. Epub 2011 Aug 3. Review.

37.

Timing and uptake of ART during treatment for active tuberculosis in HIV co-infected adults in Malawi.

van Lettow M, Chan AK, Ginsburg AS, Tweya H, Gareta D, Njala J, Kanyerere H, Phiri S, Idana I.

Public Health Action. 2011 Sep 21;1(1):6-9. doi: 10.5588/pha.11.0003.

38.

New conjugate vaccines for the prevention of pneumococcal disease in developing countries.

Ginsburg AS, Alderson MR.

Drugs Today (Barc). 2011 Mar;47(3):207-14. doi: 10.1358/dot.2011.47.3.1556471. Review.

PMID:
21494698
39.

Oxygen is an essential medicine: a call for international action.

Duke T, Graham SM, Cherian MN, Ginsburg AS, English M, Howie S, Peel D, Enarson PM, Wilson IH, Were W; Union Oxygen Systems Working Group.

Int J Tuberc Lung Dis. 2010 Nov;14(11):1362-8.

40.

Provision of care following prevention of mother-to-child HIV transmission services in resource-limited settings.

Ginsburg AS, Hoblitzelle CW, Sripipatana TL, Wilfert CM.

AIDS. 2007 Nov 30;21(18):2529-32. Review.

PMID:
18025890
41.

Diagnosis of pediatric human immunodeficiency virus infection in resource-constrained settings.

Ginsburg AS, Miller A, Wilfert CM.

Pediatr Infect Dis J. 2006 Nov;25(11):1057-64. Review.

PMID:
17072130
42.

Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model.

Ginsburg AS, Sun R, Calamita H, Scott CP, Bishai WR, Grosset JH.

Antimicrob Agents Chemother. 2005 Sep;49(9):3977-9.

43.

Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system.

Ginsburg AS, Lee J, Woolwine SC, Grosset JH, Hamzeh FM, Bishai WR.

Antimicrob Agents Chemother. 2005 Feb;49(2):853-6.

44.

Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.

Ginsburg AS, Hooper N, Parrish N, Dooley KE, Dorman SE, Booth J, Diener-West M, Merz WG, Bishai WR, Sterling TR.

Clin Infect Dis. 2003 Dec 1;37(11):1448-52. Epub 2003 Nov 4.

PMID:
14614666
45.

The rapid development of fluoroquinolone resistance in M. tuberculosis.

Ginsburg AS, Woolwine SC, Hooper N, Benjamin WH Jr, Bishai WR, Dorman SE, Sterling TR.

N Engl J Med. 2003 Nov 13;349(20):1977-8. No abstract available.

PMID:
14614180
46.

Fluoroquinolones, tuberculosis, and resistance.

Ginsburg AS, Grosset JH, Bishai WR.

Lancet Infect Dis. 2003 Jul;3(7):432-42. Review.

PMID:
12837348
47.
48.

Sperm-egg association and its relationship to the activation of the egg in salmonid fishes.

GINSBURG AS.

J Embryol Exp Morphol. 1963 Mar;11:13-33. No abstract available.

49.
50.

[Parthenogenetic development as one of the causes of roe loss in the sturgeon].

DETLAF TA, GINSBURG AS.

Dokl Akad Nauk SSSR. 1951 Feb 21;76(6):963-6. Undetermined Language. No abstract available.

PMID:
14813180

Supplemental Content

Loading ...
Support Center